High Intensity Interval Training in Osteoarthritis, Effects on Metabolomics

October 27, 2017 updated by: University of North Carolina, Chapel Hill

Feasibility and Initial Effects of High Intensity Interval Training on Knee Osteoarthritis: an Exploratory Evaluation on Metabolomics

Purpose: The purpose of this study will be to examine the feasibility and acceptability of a 6-week high intensity interval training (HIIT) program in patients with knee OA symptoms ranging from mild to severe. A secondary purpose will be to evaluated changes in whole body metabolism induced by 6-weeks of HIIT.

Participants: Fifteen patients (age 40-70 yrs; BMI 20-35 kg/m²) with symptomatic knee OA

Procedures (methods): All participants will be assigned to the single-arm of the study in which all participants will receive 6 weeks of HIIT, delivered twice per week. Outcomes will be assessed at baseline and 6 weeks. The primary outcome will evaluate tolerability, feasibility, acceptability, compliance, and adherence to the HIIT program. Secondary outcomes will include whole body metabolism markers, inflammation, and a set of physical function including knee osteoarthritis symptomatic burden and pain, cardiorespiratory fitness, isometric knee extensor and flexor strength (factors associated with physical function and symptomatic knee OA progression), and body composition.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Chapel Hill, North Carolina, United States, 27599
        • Applied Physiology Laboratory

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Must exhibit symptomatic knee OA (WOMAC > 31), radiographic evidence of tibiofemoral OA (2-4 Kellgren-Lawrence scale)
  • Age 40-70 years
  • Body mass index 20-35 kg/m²
  • Cleared by study physician from 12 lead EKG and medical history review

Exclusion Criteria:

  • Individuals diagnosed with a cardiovascular condition restricting exercise Individuals currently meeting Department of Health and Human Services Guidelines for Physical Activity (meeting >150 minutes of exercise per week)
  • Individuals currently doing HIIT
  • Individuals currently participating in physical therapy for knee OA
  • Individuals currently participating in another OA intervention study
  • Received a corticosteroid or hyaluronic acid injection involved in the knee in the previous 3 weeks or scheduled for during the intervention
  • Diagnosis of gout in the knee
  • Diagnosis of Rheumatoid arthritis
  • Diagnosis of Fibromyalgia
  • Other systemic rheumatic disease
  • Severe dementia or other memory loss
  • Active diagnosis of psychosis or uncontrolled substance abuse disorder
  • Hospitalization for a stroke, heart attack, or heart failure, or had surgery for blocked arteries in the past 6 months
  • Diabetics (medications include exogenous insulin)
  • Total joint replacement knee surgery, other knee surgery, meniscus tear, or ACL tear in the past 12 months
  • On a waiting list for total joint replacement
  • Severely impaired hearing or speech
  • Pregnant or planning to become pregnant in the next 8 weeks
  • Inability to speak English
  • Serious or terminal illness as indicated by referral to hospice or palliative care
  • Nursing home residence
  • Inability to ride a stationary bike
  • Any other health problems that would prohibit safe participation in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High intensity interval training
Each training session will consist of a 3-5 minute warm-up, followed by 10 repetitions of 1-minute bouts at individualized training intensity with 1-minute rest periods.
Other Names:
  • Stationary bike

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Feasibility - proportion of potential participants screened for the study who are enrolled
Time Frame: baseline
baseline
Feasibility - retention: proportion of enrolled participants retained at 6-weeks post testing
Time Frame: 6 weeks
6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Compliance: average number of training session completed per week
Time Frame: 6 weeks
6 weeks
Adherence: total number of training session completed per week
Time Frame: 6 weeks
6 weeks
Adherence: total number of training weeks completed
Time Frame: 6 weeks
6 weeks
Whole body metabolism measured by insulin
Time Frame: 6 weeks
6 weeks
Whole body metabolism measured by amino acids
Time Frame: 6 weeks
6 weeks
Whole body metabolism measured by free fatty acids
Time Frame: 6 weeks
6 weeks
Whole body metabolism measured by an oral glucose tolerance test
Time Frame: 6 weeks
6 weeks
Inflammation measured from interleukin-6 and tumor necrosis factor alpha
Time Frame: 6 weeks
6 weeks
Change in Pain score from baseline to 6 weeks
Time Frame: baseline, 6 weeks
Determined from WOMAC pain subscale (range 0-20)
baseline, 6 weeks
Change in symptomatic burden score from baseline to 6 weeks
Time Frame: baseline, 6 weeks
Determined from the total WOMAC (range 0-96)
baseline, 6 weeks
Cardiorespiratory Fitness from peak oxygen consumption test
Time Frame: 6 weeks
6 weeks
Knee Strength (extensors and flexors) from dynamometry
Time Frame: 6 weeks
6 weeks
Body Composition from dual energy x-ray absorptiometry
Time Frame: 6 weeks
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Actual)

October 1, 2017

Study Completion (Actual)

October 1, 2017

Study Registration Dates

First Submitted

January 18, 2017

First Submitted That Met QC Criteria

January 30, 2017

First Posted (Estimate)

February 1, 2017

Study Record Updates

Last Update Posted (Actual)

October 31, 2017

Last Update Submitted That Met QC Criteria

October 27, 2017

Last Verified

October 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 16-0829
  • 1P2CHD086851-01 (U.S. NIH Grant/Contract)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on High intensity interval training

Subscribe